Cargando…

Adherence to lipid-lowering treatment: the patient perspective

Despite the widespread prescription of highly effective lipid-lowering medications, such as the HMG-CoA reductase inhibitors (statins), a large portion of the population has lipid levels higher than the recommended goals. Treatment failures have been attributed to a variety of causes but the most im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casula, Manuela, Tragni, Elena, Catapano, Alberico Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496534/ https://www.ncbi.nlm.nih.gov/pubmed/23152673 http://dx.doi.org/10.2147/PPA.S29092

Ejemplares similares

Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review
por: Olmastroni, Elena, et al.
Publicado: (2023)

Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic
por: Olmastroni, Elena, et al.
Publicado: (2022)

Antibiotic Prescription in the Community-Dwelling Elderly Population in Lombardy, Italy: A Sub-Analysis of the EDU.RE.DRUG Study
por: Galimberti, Federica, et al.
Publicado: (2022)

Prevalence of the Prescription of Potentially Interacting Drugs
por: Tragni, Elena, et al.
Publicado: (2013)

Correction: Prevalence of the Prescription of Potentially Interacting Drugs
por: Tragni, Elena, et al.
Publicado: (2013)

Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet)
por: Casula, Manuela, et al.
Publicado: (2022)

Potentially Inappropriate Prescribing among Elderly Outpatients: Evaluation of Temporal Trends 2012–2018 in Piedmont, Italy
por: Galimberti, Federica, et al.
Publicado: (2022)

Reduction of Cardio-Metabolic Risk and Body Weight through a Multiphasic Very-Low Calorie Ketogenic Diet Program in Women with Overweight/Obesity: A Study in a Real-World Setting
por: Tragni, Elena, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies
por: Casula, Manuela, et al.
Publicado: (2022)

Evaluation of Factors Associated With Appropriate Drug Prescription and Effectiveness of Informative and Educational Interventions—The EDU.RE.DRUG Project
por: Galimberti, Federica, et al.
Publicado: (2022)

A pragmatic controlled trial to improve the appropriate prescription of drugs in adult outpatients: design and rationale of the EDU.RE.DRUG study
por: Casula, Manuela, et al.
Publicado: (2020)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives
por: Catapano, Alberico Luigi, et al.
Publicado: (2017)

Adherence to Mediterranean Diet: A Population-Based Longitudinal Cohort Study
por: Mattavelli, Elisa, et al.
Publicado: (2023)

HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role
por: Casula, Manuela, et al.
Publicado: (2021)

Twelve Variants Polygenic Score for Low‐Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations
por: Olmastroni, Elena, et al.
Publicado: (2022)

The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group
por: Gazzotti, Marta, et al.
Publicado: (2022)

Corrigendum: The role of registers in increasing knowledge and improving management of children and adolescents affected by familial hypercholesterolemia: The LIPIGEN pediatric group
por: Gazzotti, Marta, et al.
Publicado: (2023)

Adherence to the Mediterranean Diet: Impact of Geographical Location of the Observations
por: Mattavelli, Elisa, et al.
Publicado: (2022)

The management of patients with chronic cardiovascular therapies in Lombardy region: The impact of the COVID-19 pandemic
por: Galimberti, F., et al.
Publicado: (2022)

Lower Rate of Cardiovascular Complications in Patients on Bolus Insulin Analogues: A Retrospective Population-Based Cohort Study
por: Cammarota, Simona, et al.
Publicado: (2013)

Update on the management of severe hypertriglyceridemia – focus on free fatty acid forms of omega-3
por: Pirillo, Angela, et al.
Publicado: (2015)

The Effectiveness of Interventions to Evaluate and Reduce Healthcare Costs of Potentially Inappropriate Prescriptions among the Older Adults: A Systematic Review
por: Mucherino, Sara, et al.
Publicado: (2022)

Effect of Lipids and Lipoproteins on Hematopoietic Cell Metabolism and Commitment in Atherosclerosis
por: Baragetti, Andrea, et al.
Publicado: (2021)

Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases
por: Pirillo, Angela, et al.
Publicado: (2013)

Multifactorial Activation of NLRP3 Inflammasome: Relevance for a Precision Approach to Atherosclerotic Cardiovascular Risk and Disease
por: Baragetti, Andrea, et al.
Publicado: (2020)

Molecular Immune-Inflammatory Connections between Dietary Fats and Atherosclerotic Cardiovascular Disease: Which Translation into Clinics?
por: Mattavelli, Elisa, et al.
Publicado: (2021)

High density lipoproteins and atherosclerosis: emerging aspects
por: Sala, Federica, et al.
Publicado: (2012)

Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia
por: Olmastroni, Elena, et al.
Publicado: (2023)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

Inclisiran: How Widely and When Should We Use It?
por: Pirillo, Angela, et al.
Publicado: (2022)

Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease
por: Desai, Nihar R., et al.
Publicado: (2022)

Transatlantic Lipid Guideline Divergence: Same Data But Different Interpretations
por: Orringer, Carl E., et al.
Publicado: (2020)

Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases
por: Bonacina, Fabrizia, et al.
Publicado: (2013)

Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
por: Rea, Federico, et al.
Publicado: (2021)

Geographical Variation in Medication Prescriptions: A Multiregional Drug-Utilization Study
por: Russo, Veronica, et al.
Publicado: (2020)

New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia
por: Pirillo, Angela, et al.
Publicado: (2022)

Molecular Mechanisms Responsible for the Antiinflammatory and Protective Effect of HDL on the Endothelium
por: Norata, Giuseppe D, et al.
Publicado: (2005)

Treatment approaches and adherence to urate-lowering therapy for patients with gout
por: Aung, Thanda, et al.
Publicado: (2017)

COPD: adherence to therapy
por: Sanduzzi, Alessandro, et al.
Publicado: (2014)

Combination therapy in cholesterol reduction: focus on ezetimibe and statins
por: Grigore, Liliana, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_uiegdqbk68kmisjv2cu90c88h2